These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1016971)

  • 1. Comparison of the biologic activity of VP-16-213 given iv and orally in capsules or drink ampules.
    Brunner KW; Sonntag RW; Ryssel HJ; Cavalli F
    Cancer Treat Rep; 1976 Sep; 60(9):1377-9. PubMed ID: 1016971
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide.
    Stewart DJ; Nundy D; Maroun JA; Tetreault L; Prior J
    Cancer Treat Rep; 1985 Mar; 69(3):269-73. PubMed ID: 3884152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of a new form of an oral administration of VP-16-213.
    Lau ME; Hansen HH; Nissen NI; Pedersen H
    Cancer Treat Rep; 1979 Mar; 63(3):485-7. PubMed ID: 371801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of oral etoposide in small cell carcinoma of the lung].
    Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Kawakami Y; Shimizu T; Onodera S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1244-7. PubMed ID: 6329103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
    Konishi I; Kitani T; Nagai K; Kanamaru A; Kohsaki M; Masaoka T; Shibata H; Horiuchi A; Tsubaki K; Kawagoe H
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1482-6. PubMed ID: 4015122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration].
    Furuse K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2352-7. PubMed ID: 3000299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide infusions for treatment of metastatic lung cancer.
    Steward WP; Thatcher N; Edmundson JM; Shiu W; Wilkinson PM
    Cancer Treat Rep; 1984 Jun; 68(6):897-9. PubMed ID: 6329509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study.
    Vaughn CB; Panettiere F; Thigpen T; Bottomley R; Hoogstraten B; Samal B
    Cancer Treat Rep; 1981; 65(5-6):443-5. PubMed ID: 7237465
    [No Abstract]   [Full Text] [Related]  

  • 9. [A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].
    Wakui A; Yokoyama M; Takahashi H; Yoshida Y; Sakata Y; Sato S; Kano A; Kawamoto K; Hashimoto S; Konno K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):319-29. PubMed ID: 3947109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of etoposide for pulmonary metastases from urogenital tract cancer].
    Fujita K; Murayama T; Sayama T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2438-41. PubMed ID: 6497402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y; Ohshima S; Kado M; Nakayama M; Shimokata K; Sakai S; Ito F; Chikata E; Hara K; Kanda T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of severe hypotension with VP-16-213 administered directly lv.
    Cavalli F; Sonntag RW; Ryssel HJ; Brunner KW
    Cancer Treat Rep; 1977 Oct; 61(7):1411. PubMed ID: 589604
    [No Abstract]   [Full Text] [Related]  

  • 13. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
    Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A phase II study of NK171 (etoposide)].
    Kimura K; Niitani H
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
    Yoshida T; Nakanishi J; Ito K; Kobayashi S; Ohtake S; Nakamura S; Hattori K
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1579-84. PubMed ID: 6476835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podophyllotoxin derivatives VP-16 and VM-26.
    D'Incalci M; Garattini S
    Cancer Chemother Biol Response Modif; 1987; 9():67-70. PubMed ID: 3079416
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the mechanisms of action of VP-16-213 and podophyllotoxin.
    Horwitz SB; Loike JD
    Lloydia; 1977; 40(1):82-9. PubMed ID: 875640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase I study of an oral administration of VP 16-213].
    Ogawa M; Ota K; Oyama A; Fukuoka M; Takada M; Yoshida S; Sanpi K; Kimura I; Ohnoshi T; Kuraishi Y
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2403-7. PubMed ID: 6639102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podophyllotoxin derivatives VP-16 and VM-26.
    D'Incalci M; Garattini S
    Cancer Chemother Biol Response Modif; 1988; 10():57-63. PubMed ID: 3079398
    [No Abstract]   [Full Text] [Related]  

  • 20. Etoposide by oral route in the treatment of unresectable non-small cell lung cancer.
    Scagliotti G; Lodico D; Gozzelino F; Pescetti G
    Chemioterapia; 1984 Oct; 3(5):324-6. PubMed ID: 6532545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.